Recombinant human thyrotropin in thyroid cancer and hypopituitarism due to sella metastasis

Thyroid

Volumn 9, Issue 12, 1999, Pages 1253-1256

  Risse, Jörn H ^a   Grünwald, Frank ^a   Bender, Hans ^a   Schüller, Heinrich ^a   Van Roost, Dirk ^a   Biersack, Hans Jürgen ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; RECOMBINANT HORMONE; THYROTROPIN;

AGED; ARTICLE; CANCER GROWTH; CASE REPORT; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; HYPOPITUITARISM; MALE; METASTASIS; PRIORITY JOURNAL; SELLA TURCICA; THYROID CANCER;

EID: 1642633649     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.1253     Document Type: Article

References (18)

1. Hershman JM, Blahd WH, Gorden ME 1990 Thyroid gland. In: Haskell CM (ed) Cancer Treatment. Saunders, Philadelphia, p 406-414.
2. Dow KH, Ferrell BR, Anello C 1997 Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 7:613-619.
3. Meier CA, Braverman LE, Ebner SA, Veronikis I, Daniels GH, Ross DS, Deraska DJ, Davies TF, Valentine M, DeGroot LJ, Curran P, McEllin K, Reynolds J, Robbins J, Weintraub BD 1994 Diagnostic use of human recombinant thyrotropin in patients with thyroid carcinoma (phase I/II study). J Clin Endocrinol Metab 78:188-196.
4. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896.
5. Branch CL Jr, Laws ER Jr 1987 Metastatic tumors of the sella turcica masquerading as primary pituitary tumors. J Clin Endocrinol Metab 65:469-474.
6. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl N Med 338:297-306.
7. Chiu AC, Delpassand ES, Sherman SI 1997 Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab 82:3637-3642.
8. Sziklas JJ, Mathews J, Spencer RP, Rosenberg RJ, Ergin MT, Bower BF 1985 Thyroid carcinoma metastatic to pituitary. J Nucl Med 26:1097.
9. Teears RJ, Silverman EM 1975 Clinicopathologic review of 88 cases of carcinoma metastatic to the pituitary gland. Cancer 36:216-220.
10. McCarthy DJ, Karsner HT 1912 Adenocarcinoma of the thyroid, with metastasis to the cervical glands and pituitary: A contribution to the pathology of abnormal fat formation. Am J Med Sci 144:834.
11. Johnson PM, Atkins HL 1965 Functioning metastasis of thyroid carcinoma in sella turcica. J Clin Endocrinol Metab 25:1122.
12. 99mTc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 7:327-335.
13. Cavalieri RR 1996 Nuclear imaging in the management of thyroid carcinoma. Thyroid 6:485-492.
14. 131I and recombinant human thyroid stimulating hormone. J Clin Endocrinol Metab 82:11-14.
15. Thotakura NR, Desai RK, Bates LG, Cole ES, Pratt BM, Weintraub BD 1991 Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology 128:341-348.
16. 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism. J Clin Endocrinol Metab 81:1724-1725.
17. Luster M, Reinhardt W, Körber C, Hänscheid H, Rendl J, Mann K, Reiners C 1997 Use of recombinant human TSH in a patient with metastatic follicular thyroid carcinoma and secondary hypothyroidism. J Endocrinol Invest 20(suppl 5):54.
18. Adler ML, Macapinlac HA, Robbins RJ 1998 Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin. Endocr Pract 4:282-286.